Global Epstein Barr Virus Market Overview
The Epstein-Barr virus is the most prevalent form of virus in humans, and it is one of eight varieties of human herpes viruses. The Epstein–Barr virus (EBV) is the most common cause of infectious mononucleosis, which has been linked to a variety of cancers, including gastric carcinoma, nasopharyngeal carcinoma, Burkitt lymphoma, Hodgkin lymphoma, lymphomas in immunocompromised people, and multiple sclerosis. The Epstein–Barr virus has been associated to a variety of lymphatic malignancies and lupus in numerous studies. The symptoms of this condition are similar to those of other illnesses, making detection challenging. Fatigue, fever, an inflamed throat, and an enlarged liver are all symptoms of EBV infection. Antibodies to the Epstein-Barr virus can be detected in a blood test. The presence of viral gene expression in every tumour cell, as well as proof that EBV is clonal (or oligoclonal) in tumor cells, are all requirements for EBV association with cancer. The global Epstein Barr virus market accounted for US$ 1.54 billion in 2020 and is estimated to be US$ 2.48 billion by 2030 and is anticipated to register a CAGR of 5.3%.
Impact of Covid-19 pandemic on market
A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for an outbreak of Coronavirus Disease 2019 (COVID-19) in Wuhan, China, since December 2019. SARS-CoV-2 was extremely contagious and spread quickly. According to COVID-19 patients' laboratory results, some of them tested positive for Epstein-Barr virus (EBV) viral capsid antigen (VCA) IgM antibodies. Despite the fact that EBV infection affects up to 90% of the adult population, most immunocompetent patients show no clinical symptoms following infection . It can, however, be reactivated and spread in immunocompromised people, resulting in death. Burkitt lymphoma, nasopharyngeal carcinomas, and T-cell/NK lymphoma have all been linked to EBV infection, as have autoimmune illnesses including systemic lupus erythematosus (SLE) and multiple sclerosis. The pathology report of a COVID-19 dead patient recently showed that T cells were overactivated, which led to significant immunological damage in COVID-19 patients to some extent. Furthermore, COVID-19 and EBV-induced infectious mononucleosis (IM) share symptoms such as fever, tiredness, myalgia, anorexia, and sore throat, indicating a possible link.
Global Epstein Barr Virus Market Dynamics
Growth in business operations by emerging and small sized players
Several universities are frequently engaged in research and development for the production of innovative monovaccines. For example, the University of Kansas School of Engineering and School of Pharmacy has been researching the genetics of human immune responses in order to develop a powerful Epstein–Barr virus (EBV) vaccine since 2017. The global Epstein–Barr virus vaccine market is likely to be driven by rising research activity by various organizations for the development of innovative EBV vaccines. The market is being driven by advances in serological testing for Epstein-Barr virus infection. Furthermore, the market is being driven by the demand for innovative medicines to treat Epstein-Barr virus infections. Growing public awareness of therapeutic options, as well as technical advancements, are all propelling the market forward.
Global Epstein Barr Virus Market Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
Source: Prophecy Market Insights
The global Epstein Barr virus market is segmented based on test, application, and region.
On the basis of Test, the global Epstein barr virus market is segmented into Complete Blood Count Test, Monospot test and Others. Based on Application, the target market is segmented mononucleosis, gastric carcinoma, multiple sclerosis, and others.
Regional Insights:
On region the global Epstein Barr virus market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. During the forecast period, North America is expected to have a significant proportion of the global Epstein–Barr virus vaccines market. This is expected to grow due to a high rate of EBV infection, high diagnosis rate, well-developed health-care infrastructure, and a big number of R&D activities. The market for Epstein–Barr virus vaccines in Asia and the Middle East is expected to grow due to an increase in the incidence of chronic diseases, government involvement in improving health care facilities, and an increase in disposable income in these regions.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Test- Complete Blood Count Test, Monospot test and Others By Application–Mononucleosis, Gastric carcinoma, Multiple sclerosis, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Epstein barr virus market report based on test, application, and region.
Global Epstein Barr Virus Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Epstein Barr Virus Market Key Players
The key players operating in the global Epstein Barr virus market includes Abbott, Bio-Rad Laboratories, Inc., Danaher Corporation, Cardinal Health Inc., Thermo Fischer Scientific Inc., and Others.
Global Epstein Barr Virus Market Company Profile
- Abott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Cardinal Health Inc.
- Thermo Fischer Scientific Inc.
- Others
“*” marked represents similar segmentation in other categories in the respective section
Global Epstein Barr Virus Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Epstein Barr Virus Strategies
- Key Questions this Study will Answer
- Market Snippet, By Test
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Epstein Barr Virus Market, By Test , 2020 – 2030, (US$ Mn)
- Complete Blood Count Test
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Monospot Test
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Complete Blood Count Test
- Global Epstein Barr Virus Market, By Application, 2020 – 2030, (US$ Mn)
- Mononucleosis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Gastric carcinoma
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Multiple sclerosis
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Others
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Mononucleosis
- Global Epstein Barr Virus Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Test , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Test , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Test , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Test , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Test , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
-
- Abbott
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Cardinal Health Inc.
- Thermo Fischer Scientific Inc.
- Others
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The global Epstein Barr virus market is segmented based on test, application, and region.
The global Epstein–Barr virus vaccine market is likely to be driven by rising research activity by various organizations for the development of innovative EBV vaccines.
North America is expected to have a significant proportion of the global Epstein–Barr virus vaccines market. This is expected to grow due to a high rate of EBV infection, high diagnosis rate, well-developed health-care infrastructure, and a big number of R&D activities
The majority of institutions are working on Epstein–Barr virus vaccines and finding new research, but with only a few private players investing in new Epstein–Barr virus vaccines. .